BRPI0921791A2 - Composições de polímeros de dihidroxiacetona e usos das mesmas - Google Patents

Composições de polímeros de dihidroxiacetona e usos das mesmas

Info

Publication number
BRPI0921791A2
BRPI0921791A2 BRPI0921791-6A BRPI0921791A BRPI0921791A2 BR PI0921791 A2 BRPI0921791 A2 BR PI0921791A2 BR PI0921791 A BRPI0921791 A BR PI0921791A BR PI0921791 A2 BRPI0921791 A2 BR PI0921791A2
Authority
BR
Brazil
Prior art keywords
dihydroxyacetone
polymer compositions
compositions
polymer
dihydroxyacetone polymer
Prior art date
Application number
BRPI0921791-6A
Other languages
English (en)
Inventor
David Putnam
Peter Zaweneh
Jason Spector
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of BRPI0921791A2 publication Critical patent/BRPI0921791A2/pt
Publication of BRPI0921791B1 publication Critical patent/BRPI0921791B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/42—Chemical after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
BRPI0921791A 2008-11-03 2009-11-03 uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos BRPI0921791B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11073408P 2008-11-03 2008-11-03
PCT/US2009/063177 WO2010062783A2 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof

Publications (2)

Publication Number Publication Date
BRPI0921791A2 true BRPI0921791A2 (pt) 2015-08-25
BRPI0921791B1 BRPI0921791B1 (pt) 2018-10-30

Family

ID=42226353

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921791A BRPI0921791B1 (pt) 2008-11-03 2009-11-03 uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos

Country Status (6)

Country Link
US (2) US8916143B2 (pt)
EP (1) EP2362788B1 (pt)
JP (1) JP5788326B2 (pt)
CN (2) CN104774326B (pt)
BR (1) BRPI0921791B1 (pt)
WO (1) WO2010062783A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用
CA3149284A1 (en) 2009-12-15 2011-07-14 Incept, Llc Implants and biodegradable fiducial markers
AU2016311704B2 (en) 2015-08-24 2018-11-29 Shanxi Yabao Investment Group Co., Ltd Use of dihydroxyacetone in preparation of anti-cancer medicaments
WO2017177088A1 (en) * 2016-04-07 2017-10-12 Cornell University Polymeric dha-containing biodegradable compositions and surgical barrier devices made thereof
US10590257B2 (en) 2016-09-26 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications
US11975123B2 (en) 2018-04-02 2024-05-07 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US12599706B2 (en) 2017-04-03 2026-04-14 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US11969526B2 (en) 2017-04-03 2024-04-30 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
CN107141464B (zh) * 2017-05-14 2019-02-19 辽宁大学 一种通过希夫碱载药的两亲性聚碳酸酯聚乙二醇聚合物及其制备方法和应用
EP3860613B1 (en) 2018-10-01 2025-09-10 The Board of Trustees of the Leland Stanford Junior University Injectable hydrogels for controlled release of immunomodulatory compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049795A (en) * 1971-05-14 1977-09-20 Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie Treatment of hemorrhagic shock
EP0884045A1 (en) * 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US7659420B2 (en) * 2004-05-05 2010-02-09 Cornell Research Foundation, Inc Dihydroxyacetone-based polymers
US7910135B2 (en) * 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
US20100104623A1 (en) 2007-02-28 2010-04-29 National University Corporation Hokkaido University Kyoto University And Shionogi & Co Ltd Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用

Also Published As

Publication number Publication date
EP2362788A2 (en) 2011-09-07
US20150079019A1 (en) 2015-03-19
CN102264399A (zh) 2011-11-30
CN104774326A (zh) 2015-07-15
BRPI0921791B1 (pt) 2018-10-30
WO2010062783A2 (en) 2010-06-03
CN104774326B (zh) 2017-04-12
JP2012508173A (ja) 2012-04-05
EP2362788B1 (en) 2016-06-01
US9629870B2 (en) 2017-04-25
US8916143B2 (en) 2014-12-23
EP2362788A4 (en) 2013-04-03
WO2010062783A3 (en) 2010-07-22
JP5788326B2 (ja) 2015-09-30
CN102264399B (zh) 2015-03-25
US20110212049A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
BRPI0921791A2 (pt) Composições de polímeros de dihidroxiacetona e usos das mesmas
BRPI1008709A2 (pt) composições e usos das mesmas.
EP2352781A4 (en) BIODEGRADABLE POLYMERIC COMPOSITION
EP2473555A4 (en) POLYMER COMPOSITIONS
BRPI0915738A2 (pt) composição de polímero reticulável
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
EP2270104A4 (en) POLYMER ELECTROLYTE COMPOSITION
BRPI0911656A2 (pt) formulações de nanopartículas e usos das mesmas
EP2315796A4 (en) COMPOSITION OF RETICULATED POLYMERS
BRPI0918499A2 (pt) polímeros reticulados
BRPI0912284A2 (pt) Polímeros antimicrobianos e seus usos
BRPI0716253A2 (pt) glioxalaÇço de polÍmero de vinilamida
BRPI1009677A2 (pt) Gelificação de polímero de óleos
BRPI1015336A2 (pt) composições para tratamento de tecidos que compreendem polímeros de organossiloxano
PT2355853T (pt) Conjugados polímero biodegradável ¿ unidade bioativa
EP2246377A4 (en) Resin composition
DE602008001230D1 (de) Verbesserte Polymerzusammensetzung
DOP2011000363A (es) Composiciones pesticidas que incluyen coadyuvantes polimericos
EP2524932A4 (en) POLYMER ELECTROLYTE POLYMERIC COMPOSITION
BRPI0920569A2 (pt) aditivos de polimero
BRPI0924103A2 (pt) usos de thaxtomin e composições de thaxtomin como herbicidas
EP2308905A4 (en) HARDENABLE COPOLYMER AND HARDENABLE RESIN COMPOSITION
BRPI1013222A2 (pt) composições de mirceno polimérico
GB0901103D0 (en) Polymer composition
EP2345682A4 (en) POLYMER ELECTROLYTE MEMBRANE

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09A Decision: intention to grant
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/11/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2538 DE 27-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.